Evidence map›Paper›PMID 32158328›Full record

ArticleYonago acta medica2020

Prognostic Significance of C-reactive Protein-to-prealbumin Ratio in Patients with Esophageal Cancer.

Tomoyuki Matsunaga, Hiroshi Miyata, Keijiro Sugimura, Masaaki Motoori, Kei Asukai, Yoshitomo Yanagimoto, Kazuyoshi Yamamoto, Hirofumi Akita, Junichi Nishimura, Hiroshi Wada and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Yonago acta medica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. C-reactive protein and digestive pathologies: A narrative review for daily clinical use.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Tomoyuki MatsunagaDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Hiroshi MiyataDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Keijiro SugimuraDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Masaaki MotooriDepartment of Surgery, Osaka General Medical Center, Osaka 558-8558, Japan.
Kei AsukaiDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Yoshitomo YanagimotoDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Kazuyoshi YamamotoDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Hirofumi AkitaDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Junichi NishimuraDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Hiroshi WadaDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Hidenori TakahashiDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Masayoshi YasuiDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Takeshi OmoriDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Masayuki OhueDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Yoshiyuki FujiwaraDivision of Surgical Oncology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
Masahiko YanoDepartment of Digestive Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Osaka Medical Center for Cancer and Cardiovascular Diseases · JPOsaka International Cancer Institute · JPOsaka City General Hospital · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic value of combination of C-reactive protein and prealbumin (CRP/PAlb) in esophageal cancer remains unclear.

methodsWe enrolled 167 esophageal cancer patients who underwent curative esophagectomy. Univariate and multivariate analyses were performed to determine the prognostic significance of various markers, including CRP-to-albumin (CRP/Alb) ratio, modified Glasgow prognostic score, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index.

resultsReceiver operating characteristic analysis revealed the optimal cut-off value of each inflammatory factor, and CRP/PAlb ratio had the greatest discriminative power in predicting recurrence-free survival (RFS) among the examined measures (AUC 0.668). The 5-year overall survival and RFS rates were significantly lower in patients with high CRP/PAlb ratio than in those with low CRP/PAlb ratio (

conclusionCRP/PAlb ratio was useful for predicting the prognosis of esophageal cancer patients.

Indexed as

C-reactive protein-to-prealbumin ratioesophageal canceresophagectomyinflammatory markerprognosis

Identifiers

PMID32158328
PMCPMC7028532
OpenAlexW3007595765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.